An Analysis of Conditional Survival Rates for Ewing Sarcoma Patients
- 1 Statistical Consultant, Plano, TX, USA
Abstract
Using data from the Surveillance, Epidemiology, and End Results (SEER) Program based at the National Cancer Institute in the US, conditional survival rates are reported for 1,988 Ewing Sarcoma patients diagnosed during the period 2000-201 5 . These patients represent the experience of 26.5% of the US population. Specifically, 5-year conditional relative survival rates are calculated for these patients for the first eight years subsequent to diagnosis of their cancer by Extent of Disease (EOD) (Localized, Regional, and Distant as coded by the SEER Program), gender, and age (<18, 18 - 34, and 35+). Findings include showing how the conditional survival rate patterns improve over time and that there are differences by gender, age, and EOD.
- Ewing Sarcoma and Undifferentiated Small Round Cell Sarcomas of Bone and Soft Tissue Treatment (PDQ®), Health Professional Version, NCI (cancer.gov). https://www.cancer.gov/publications/pdq
- American Joint Committee on Cancer. ACS (facs.org) SEER Stat Variables (cancer.gov). https://www.facs.org/quality-programs/cancer-programs/american-joint-committee-on-cancer/
- SEER Stat Variables. https://seer.cancer.gov/search?q=seer+historic+stage&x=138y=13
- SEER*Stat Software. https://seer.cancer.gov/data-software/documentation/seerstat/
- https://seer.cancer.gov/seerstat/
- https://www.cancer.org/cancer/ewing-tumor/causes-risks-prevention/prevention.html
- Hankey, B.F. and Steinhorn, S.C. (1982) Long-Term Patient Survival for Some of the More Frequently Occurring Cancers. Cancer, 50, 1904-1912. https://doi.org/10.1002/1097-0142(19821101)50:9 3.0.CO;2-S